| Literature DB >> 29317721 |
Fang Yang1,2, Yanmin Zheng1,2, Xihui Jiang1,2, Zhengyan Su1,2, Ya Wang1,2, Lin Lin1,2, Houning Lv1,2, Jie Zhang1,2, Jingwen Zhao1,2, Bangmao Wang1,2, Kui Jiang3,4, Chao Sun5,6.
Abstract
As the world's most populated and rapidly aging country, there is limited information on sex-related differences in factors regarding uncomplicated colonic diverticulosis in China. We aimed to investigate sex differences in individual risk factor in a northern metropolis. Patients with colonic diverticulosis who underwent indicated colonoscopy were queried with respect to medical history and demographic features. Demographic information, life style factors and co-morbidities were retrieved from a prospective dataset. Multiple regression analyses were performed to determine precipitating factors of diverticula. Of 4,386 enrolled patients, colonic diverticulosis were detected in 218 cases (4.97%). Multiple logistic regression analysis implicated increasing age (OR = 1.05, 95%CI 1.03-1.06, P < 0.001), red meat ≥100 g/d (OR = 2.53, 95%CI 1.72-3.70, P < 0.001), smoking (OR = 2.14, 95%CI 1.05-4.33, P = 0.035), rheumatologic diseases (OR = 3.38, 95%CI 1.09-10.5, P = 0.035) and NSAIDs (OR = 2.11, 95%CI 1.12-3.97, P = 0.020) were significantly associated with diverticulosis in men, whilst advancing age (OR = 1.03, 95%CI 1.01-1.05, P = 0.013), BMI (OR = 1.12, 95%CI 1.04-1.19, P = 0.001), smoking (OR = 10.2, 95%CI 2.81-37.4, P < 0.001), rheumatologic diseases (OR = 8.04, 95%CI 3.05-21.2, P < 0.001), hypertension (OR = 1.76, 95%CI 1.01-3.06, P = 0.047), colonic polyps (OR = 3.12, 95%CI 1.82-5.36, P < 0.001) and antihypertensive medications (OR = 2.99, 95%CI 1.66-5.39, P < 0.001) in women. In conclusion, it is pivotal to take account of differentially sex-related factors in regard to the development of uncomplicated colonic diverticulosis.Entities:
Mesh:
Year: 2018 PMID: 29317721 PMCID: PMC5760586 DOI: 10.1038/s41598-017-18517-1
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Flow diagram of patients included for current study.
Sex differences in baseline characteristics of the study population.
| Characteristics | Men (n = 2,044) | Women (n = 2,342) |
| Cohen’s D |
|---|---|---|---|---|
|
| ||||
| Age (years), mean (SD) | 52.6 (14.4) | 54.7 (12.9) | < | 0.15 |
| Age (years), n (%) | < | 0.29 | ||
| ≤39 | 460 (22.5) | 319 (13.6) | ||
| 40–49 | 303 (14.8) | 289 (12.4) | ||
| 50–59 | 489 (23.9) | 784 (33.5) | ||
| 60–69 | 597 (29.2) | 755 (32.2) | ||
| ≥70 | 195 (9.6) | 195 (8.3) | ||
| Education (years), n (%) | 0.999 | 0.00 | ||
| ≤6 | 172 (8.4) | 197 (8.4) | ||
| 07-Sep | 496 (24.3) | 570 (24.3) | ||
| 10-Dec | 516 (25.2) | 592 (25.3) | ||
| >12 | 860 (42.1) | 983 (42.0) | ||
| Residence, n (%) | 0.870 | 0.01 | ||
| Urban | 1,649 (80.7) | 1,894 (80.9) | ||
| Rural | 395 (19.3) | 448 (19.1) | ||
| BMI (kg/m2), mean (SD) | 24.2 (3.1) | 23.0 (3.4) | < | 0.37 |
| BMI, n (%) |
| 0.31 | ||
| <25 | 1,313 (64.2) | 1,834 (78.3) | ||
| 25–30 | 649 (31.8) | 412 (17.6) | ||
| >30 | 82 (4.0) | 96 (4.1) | ||
| Exercise habit, n (%) | <0.001 | 0.26 | ||
| ≤3 times/week | 857 (41.9) | 1,281 (54.7) | ||
| >3 times/week | 1,187 (58.1) | 1,061 (45.3) | ||
| Red Meat, n (%) |
| 0.32 | ||
| <100 g/d | 1,594 (78.0) | 2,138 (91.3) | ||
| ≥100 g/d | 450 (22.0) | 204 (8.7) | ||
| Smoking index, n (%) |
| 0.85 | ||
| Nonsmoker | 1,162 (56.8) | 2,314 (98.8) | ||
| <400 | 294 (14.4) | 12 (0.5) | ||
| ≥400 | 588 (28.8) | 16 (0.7) | ||
| Alcohol consumption, n (%) |
| 0.54 | ||
| Non-drinker | 1,548 (75.7) | 2,315 (98.8) | ||
| Light/Moderate drinker (1–350 g/week) | 96 (4.7) | 27 (1.2) | ||
| Heavy drinker (≥351 g/week) | 400 (19.6) | 0 (0) | ||
|
| ||||
| Hypertension | 371 (18.2) | 428 (18.3) | 0.915 | 0.00 |
| Diabetes mellitus | 151 (7.4) | 143 (6.1) | 0.09 | 0.05 |
| Coronary heart disease | 94 (4.6) | 111 (4.7) | 0.826 | 0.00 |
| Colonic polyps | 1,030 (50.4) | 919 (39.2) | < | 0.22 |
| Upper gastrointestinal diseasesa | 151 (7.4) | 164 (7.0) | 0.622 | 0.02 |
| Hepato-biliary diseasesb | 92 (4.5) | 86 (3.7) | 0.165 | 0.04 |
| Dyslipidemia | 46 (2.3) | 64 (2.7) | 0.308 | 0.03 |
| Rheumatologic diseasesc | 46 (2.3) | 43 (1.8) | 0.331 | 0.03 |
| Miscellaneousd | 186 (9.1) | 203 (8.7) | 0.616 | 0.01 |
|
| ||||
| NSAIDs | 115 (5.6) | 125 (5.3) | 0.675 | 0.01 |
| Corticosteroid | 25 (1.2) | 32 (1.4) | 0.676 | 0.02 |
| PPIs | 123 (6.0) | 169 (7.2) | 0.112 | 0.05 |
| Mucosal protective drugs | 432 (21.1) | 607 (25.9) | < | 0.12 |
| Antihypertension drugs | 363 (17.8) | 422 (18.0) | 0.823 | 0.01 |
| Hypoglycemic medications | 149 (7.3) | 138 (5.9) | 0.62 | 0.05 |
Data are expressed as mean ± SD or number (percentage).
BMI body mass index, NSAIDs non-steroidal anti-inflammatory drugs, PPIs proton pump inhibitors.
aReflux esophagitis, atrophic gastritis, chronic gastritis, etc.
bCholelithiasis and fatty liver disease.
cRheumatoid arthritis and gout.
dOsteoporosis, arrhythmia, cerebral infarction, thyroid diseases, prostate diseases, etc.
The sex differences in risk factors of colonic diverticulosis on univariate analyses.
| Men | Women | |||||
|---|---|---|---|---|---|---|
| Div (+) (n = 148) | Div (−) (n = 1,896) |
| Div (+) (n = 70) | Div (−) (n = 2,272) |
| |
| Age, (years), mean (SD) | 59.5 (10.6) | 52 (14.5) |
| 58.0 (11.8) | 54.6 (12.9) |
|
| Age (years), n (%) |
|
| ||||
| ≤39 | 6 (4.0) | 285 (15.0) | 10 (14.3) | 309 (13.6) | ||
| 40–49 | 18 (12.2) | 440 (23.2) | 6 (8.6) | 283 (12.5) | ||
| 50–59 | 49 (33.1) | 548 (28.9) | 12 (17.1) | 772 (33.9) | ||
| 60–69 | 49 (33.1) | 169 (8.9) | 24 (34.3) | 731(32.2) | ||
| ≥70 | 26 (17.6) | 454 (24.0) | 18 (25.7) | 177 (7.8) | ||
| Education (years), n (%) | 0.971 | 0.999 | ||||
| ≤6 | 14 (9.5) | 158 (8.3) | 6 (8.6) | 191 (8.4) | ||
| 7–9 | 35 (23.6) | 461 (24.3) | 17 (24.3) | 553 (24.3) | ||
| 10–Dec | 37 (25.0) | 479 (25.3) | 18 (25.7) | 574 (25.3) | ||
| >12 | 62 (41.9) | 798 (42.1) | 29 (41.4) | 954 (42.0) | ||
| Residence, n (%) | 0.243 | 0.619 | ||||
| Urban | 114 (77.0) | 1,535 (81.0) | 55 (78.6) | 1,839 (80.9) | ||
| Rural | 34 (23.0) | 361 (19.0) | 15 (21.4) | 433 (19.1) | ||
| BMI (kg/m2), mean (SD) | 24.6 (3.4) | 24.2 (3.1) | 0.105 | 24.5 (3.8) | 22.9 (3.3) |
|
| BMI, n (%) | 0.105 |
| ||||
| <25 | 86 (58.1) | 1,227 (64.7) | 41 (58.6) | 1,793 (78.9) | ||
| 25–30 | 52 (35.1) | 597 (31.5) | 19 (27.1) | 393 (17.3) | ||
| >30 | 10 (6.8) | 72 (3.8) | 10 (14.3) | 86 (3.8) | ||
| Exercise habit, n (%) | 0.483 | 0.181 | ||||
| ≤3 times/week | 58 (39.2) | 799 (42.1) | 44 (62.9) | 1,237 (54.4) | ||
| >3 times/week | 90 (60.8) | 1,097 (57.9) | 26 (37.1) | 1,035 (45.6) | ||
| Red Meat, n (%) |
| 0.83 | ||||
| <100 g/d | 99 (66.9) | 1,495 (78.9) | 65 (92.9) | 2,073 (91.2) | ||
| ≥100 g/d | 49 (33.1) | 401 (21.1) | 5 (7.1) | 199 (8.8) | ||
| Smoking index, n (%) |
|
| ||||
| Nonsmoker | 67 (45.3) | 1,095 (57.8) | 65 (92.8) | 2,249 (99.0) | ||
| <400 | 30 (20.3) | 264 (13.9) | 1 (1.4) | 11 (0.5) | ||
| ≥400 | 51 (34.4) | 537 (28.3) | 4 (5.8) | 12 (0.5) | ||
| Alcohol consumption, n (%) | 0.153 | 0.199 | ||||
| Non-drinker | 121 (81.8) | 1,427 (75.3) | 70 (100) | 2,245 (98.8) | ||
| Light/moderate drinker | 7 (4.7) | 89 (4.7) | 0 (0) | 27 (1.2) | ||
| (1–350 g/week) | 0 (0) | 0 (0) | ||||
| Heavy drinker (≥351 g/week) | 20 (13.5) | 380 (20.0) | ||||
| Hypertension | 42 (28.4) | 329 (17.4) |
| 23 (32.9) | 405 (17.8) |
|
| Diabetes mellitus | 13 (8.8) | 138 (7.3) | 0.512 | 8 (11.4) | 135 (5.9) | 0.071 |
| Coronary heart disease | 10 (6.8) | 84 (4.4) | 0.217 | 5 (7.1) | 106 (4.7) | 0.381 |
| Colonic polyps | 81 (54.7) | 949 (50.1) | 0.306 | 42 (60.0) | 877 (38.6) |
|
| Upper gastrointestinal diseases | 12 (8.1) | 139 (7.3) | 0.728 | 5 (7.1) | 159 (7.0) | 0.963 |
| Hepato-biliary diseases | 5 (3.4) | 87 (4.6) | 0.494 | 5 (7.1) | 81 (3.6) | 0.117 |
| Dyslipidemia | 4 (2.7) | 42 (2.2) | 0.571 | 4 (5.7) | 60 (2.6) | 0.122 |
| Rheumatologic diseases | 9 (6.1) | 37 (2.0) |
| 10 (14.3) | 33 (1.5) |
|
| Miscellaneous | 14 (9.5) | 172 (9.1) | 0.874 | 10 (14.3) | 193 (8.5) | 0.09 |
| NSAIDs | 24 (16.2) | 91 (4.8) |
| 10 (14.3) | 115 (5.1) |
|
| Corticosteroid | 4 (2.7) | 21 (1.1) | 0.102 | 3 (4.3) | 29 (1.3) | 0.068 |
| PPIs | 11 (7.4) | 112 (5.9) | 0.47 | 5 (7.1) | 164 (7.2) | 1 |
| Mucosal protective drugs | 35 (23.6) | 397 (20.9) | 0.464 | 24 (34.3) | 583 (25.7) | 0.127 |
| Antihypertension medications | 40 (27.0) | 323 (17.0) |
| 22 (31.4) | 400 (17.6) |
|
| Hypoglycemic medications | 15 (10.0) | 134 (7.1) | 0.186 | 7 (10.0) | 131 (5.8) | 0.188 |
Data are expressed as mean ± SD or number (percentage).
Div (−): patients without diverticulosis.
Div (+): patients with diverticulosis.
BMI body mass index, NSAIDs non-steroidal anti-inflammatory drugs, PPIs proton pump inhibitors.
The sex differences in risk factors of colonic diverticulosis on multivariate analyses.
| Risk factors | Reference |
| Adjusted OR (95% CI) |
|
|---|---|---|---|---|
|
| ||||
| Age | — | 0.047 | 1.05 (1.03, 1.06) | < |
| Red meat ≥ 100 g/d | Red meat < 100 g/d | 0.926 | 2.53 (1.72, 3.70) |
|
| Smoking index | ||||
| <400 | Nonsmoker | 0.317 | 1.37 (0.96, 1.97) | 0.084 |
| ≥400 | Nonsmoker | 0.759 | 2.14 (1.05, 4.33) |
|
| Hypertension | Non-hypertension | 1.216 | 3.37 (0.69, 16.4) | 0.133 |
| Rheumatologic diseases | Non-rheumatologic diseases | 1.216 | 3.38 (1.09, 10.5) |
|
| NSAIDs | Non-NSAIDs | 0.748 | 2.11 (1.12, 3.97) |
|
| Antihypertension medications | Non-Antihypertension medications | 0.447 | 1.08 (0.52, 11.8) | 0.159 |
|
| ||||
| Age | — | 0.028 | 1.03 (1.01, 1.05) |
|
| BMI (kg/m²) | — | 0.109 | 1.12 (1.04, 1.19) |
|
| Smoking index | ||||
| <400 | Nonsmoker | 1.680 | 5.37 (1.03, 27.9) |
|
| ≥400 | Nonsmoker | 2.327 | 10.2 (2.81, 37.4) | < |
| Hypertension | Non-hypertension | 0.564 | 1.76 (1.01, 3.06) |
|
| Rheumatologic diseases | Non-rheumatologic diseases | 2.084 | 8.04 (3.05, 21.2) | < |
| Colonic polyps | Non-colonic polyps | 1.138 | 3.12 (1.82, 5.36) | < |
| Antihypertension drugs | Non-antihypertension drugs | 1.094 | 2.99 (1.66, 5.39) | < |
| NSAIDs | Non-NSAIDs | 0.095 | 1.10(0.46, 2.66) | 0.833 |
BMI body mass index, NSAIDs non-steroidal anti-inflammatory drugs, OR odds ratio, CI confidence interval.
Figure 2Proportion of subjects with indicated risk factor (P < 0.05 for all) and odds ratio (OR) relative to reference in study population by the presence of diverticula. Circles show the proportion (y-axis) and OR (diameter) relative to each reference. Div (+), patients with diverticulosis; Div (−), patients without diverticulosis.